| Literature DB >> 35250242 |
Eduardo Garcia-Garzon1, Ariadna Angulo-Brunet2,3, Oscar Lecuona4, Juan Ramón Barrada5, Guido Corradi1.
Abstract
Amidst a worldwide vaccination campaign, trust in science plays a significant role when addressing the COVID-19 pandemic. Given current concerns regarding research standards, we were interested in how Spanish scholars perceived COVID-19 research and the extent to which questionable research practices and potentially problematic academic incentives are commonplace. We asked researchers to evaluate the expected quality of their COVID-19 projects and other peers' research and compared these assessments with those from scholars not involved in COVID-19 research. We investigated self-admitting and estimated rates of questionable research practices and attitudes towards current research status. Responses from 131 researchers suggested that COVID-19 evaluations followed partisan lines, with scholars being more pessimistic about others' colleagues' research than their own. Additionally,researchers not involved in COVID-19 projects were more negative than their participating peers. These differences were particularly notable for areas such as the expected theoretical foundations or overall quality of the research, among others. Most Spanish scholars expected questionable research practices and inadequate incentives to be widespread. In these two aspects, researchers tended to agree regardless of their involvement in COVID-19 research. We provide specific recommendations for improving future meta-science studies, such as redefining QRPs as inadequate research practices (IRP). This change could help avoid key controversies regarding QRPs' definition while highlighting their detrimental impact. Lastly, we join previous calls to improve transparency and academic career incentives as a cornerstone for generating trust in science. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12144-022-02797-6.Entities:
Keywords: COVID-19; Inadequate incentives; Questionable research practices; Reproducibility crisis; Trust in science
Year: 2022 PMID: 35250242 PMCID: PMC8884412 DOI: 10.1007/s12144-022-02797-6
Source DB: PubMed Journal: Curr Psychol ISSN: 1046-1310
Fig. 1Average score (plus 95% confidence intervals) for the COVID-19 Research Evaluation Tool by type of involvement in COVID-19 research
Model fit indexes for the regression models fitted for the COVID-19 evaluation tool
| Model | Collaboration | Ethics | Fast publication | Key | Open practices | Opportunity | Easy to | ||
|---|---|---|---|---|---|---|---|---|---|
| Null | AIC | 649.5 | 633.9 | 522.1 | 567.6 | 627.9 | 513.8 | 532.3 | |
| BIC | 659.3 | 643.7 | 531.9 | 577.4 | 637.7 | 523.6 | 542.1 | ||
| Simple | AIC | 621.2 | 635.3 | 511.5 | 545.9 | 564.9 | 511.4 | 529.6 | |
| BIC | 637.5 | 651.5 | 527.8 | 562.2 | 581.2 | 527.8 | 545.9 | ||
| Full | AIC | 598.5 | 604.8 | 512.8 | 546.7 | 548.7 | 520.0 | 524.5 | |
| BIC | 684.0 | 689.8 | 598.4 | 632.3 | 634.3 | 605.6 | 61.0 | ||
| Null – Simple | AIC | 28.3 | -1.4 | 1.6 | 21.8 | 63.0 | 2.3 | 2.7 | |
| BIC | 21.7 | -7.9 | 4.1 | 15.2 | 56.5 | -4.2 | -3.8 | ||
| Simple—Full | AIC | 22.7 | 3.5 | -1.3 | -0.8 | 16.2 | -8.6 | 5.1 | |
| BIC | -46.5 | -38.3 | -7.5 | -7.1 | -53.1 | -77.9 | -64.1 | ||
Null: Models only including random effects. Simple: Models including COVID-19 evaluation groups as fixed predictors. Full: Models including COVID-19 evaluation groups and all sociodemographic variables as control variables. AIC: Akaike Information Criterion. BIC: Bayesian Information Criterion.
Fixed effects estimates (top) and random effect estimates (bottom) for each dependent variable
| Intercept | Researcher Group [COVID] | |||||||
|---|---|---|---|---|---|---|---|---|
| Involved (Other) [95% CI] | Not Involved [95% CI] | σ2 | τ00 | ICC | ||||
| Collaboration | 3.52 | 0.88 | 0.56 | .39 | .15/.48 | |||
| [3.23, 3.82] | ||||||||
| Ethics | 3.27 | -0.30 | 0.94 | 0.73 | .44 | .02/.45 | ||
| [2.95, 3.58] | [-0.64, 0.04] | |||||||
| Fast Publication | 2.35 | 0.35 | 0.53 | .60 | .08/.63 | |||
| [2.13, 2.58] | ||||||||
| Information | 3.46 | 0.05 | 0.57 | 0.39 | .40 | .11/.47 | ||
| [3.20, 3.70] | [-0.29, 0.38] | |||||||
| Open Practices | 4.60 | 0.78 | 0.24 | .24 | .29/.46 | |||
| [4.35, 4.85] | ||||||||
| Opportunity | 4.26 | 0.05 | 0.28 | 0.66 | .70 | .07/.72 | ||
| [4.03, 4.50] | [-0.14, 0.23] | |||||||
| Easy Publication | 2.43 | 0.02 | 0.34 | 0.68 | .66 | .07/.69 | ||
| [2.18, 2.67] | [-0.19, 0.22] | |||||||
| Quality | 3.86 | 0.63 | 0.53 | .46 | .28/.61 | |||
| [3.60, 4.12] | ||||||||
| Resources | 4.29 | 0.11 | 0.27 | 0.55 | .67 | .09/.70 | ||
| [4.07, 4.51] | [-0.07, 0.29] | |||||||
| Rigor | 3.89 | -0.15 | -0.34 | 0.43 | 1.02 | .70 | .01/.71 | |
| [3.60, 4.18] | [-0.38, 0.07] | [-0.75, 0.07] | ||||||
| Support | 3.45 | 0.21 | 0.96 | 0.14 | .13 | .09/.21 | ||
| [3.19, 3.70] | [-0.15, 0.57] | |||||||
| Theory Foundations | 3.54 | 0.80 | 0.26 | .25 | .14/.34 | |||
| [3.29, 3.79] | ||||||||
| Time to prepare | 3.20 | 0.21 | 0.45 | 0.45 | .52 | .27/.65 | ||
| [2.97, 3.43] | [-0.44, 0.02] | |||||||
| Unique Aspects | 4.20 | 0.07 | 0.58 | 0.32 | .36 | .04/.38 | ||
| [3.97, 4.43] | [-0.19, 0.33] | |||||||
Involved (Other): Evaluation of other COVID-19 research projects from researchers participating in COVID-19 projects. Not Involved: Researchers not engaging in COVID-19 projects. Significant differences at 0.05 level are presented bolded. ICC = Intraclass Coefficient. M./ C. R= Marginal / Conditional explained variance.
Expected prevalence and self-admitting rates for QRPs and novel questionable behaviors divided by COVID-19 project involvement, plus results from Agnoli et al. (2017)
| Self-admitting | Prevalence | Agnoli et al. ( | |||||
|---|---|---|---|---|---|---|---|
| Self-admitting | Expected Prevalence | ||||||
| Involved | Not involved | Involved | Not Involved | Italy | US | Italy | |
| Fail to report all measures | 48.5 | 47.9 | |||||
| Collect data until significance | 20.0 | 24.2 | 34.0 | 33.7 | |||
| Selective reporting significant conditions | 27.7 | 19.7 | 27.7 | 16.4 | |||
| Optional stopping | 6.2 | 6.1 | 27.8 | 33.0 | 15.6 | 10.4 | 37.3 |
| P-rounding | 13.8 | 15.2 | 35.8 | 38.3 | 22.0 | 22.2 | 46.8 |
| Selective reporting studies | 24.6 | 18.2 | 45.8 | 40.1 | |||
| Exclude data after observing its effect | 27.7 | 30.3 | 42.7 | 42.0 | 38.2 | 39.7 | 40.8 |
| Harking | 43.1 | 40.9 | 27.0 | 37.4 | |||
| Claiming effects hold in other conditions when unsure | 13.8 | 12.1 | 41.0 | 38.8 | 3.0 | 3.1 | 28.6 |
| 36.9 | 36.4 | - | - | - | |||
| 35.4 | 33.3 | - | - | - | |||
Involved = Researchers involved in COVID-19 projects; Not Involved = Researchers not involved in COVID-19 projects. Prevalence: Expected prevalence. QRPs with self-admitting rates or prevalence estimates over 50% are bolded . New included potential questionable behaviors are presented in italics.
Regression projects comparing researchers participating in COVID-19 or not in QRPs and the expected prevalence of the new potentially problematic behaviors
| Expected Prevalence | Self-Admission Rates | |||||
|---|---|---|---|---|---|---|
| Intercept | Involved | R2 / R2 adjusted | Intercept | Involved | R2 / R2 adjusted | |
| Exclude data after observing its effect | 42.62 | 0.06 | 0.001 / -0.009 | 0.48 | 0.05 | 0.003 / -0.005 |
| [35.38, 49.87] | [-1.51, 1.63] | [0.36, 0.61] | [-0.12, 0.23] | |||
| HARKing | 55.74 | 3.74 | 0.004 / -0.004 | 0.24 | 0.04 | 0.003 / -0.005 |
| [48.51, 62.98] | [-6.86, 14.34] | [0.14, 0.34] | [-0.19, 0.10] | |||
| Fail to report all measures/conditions | 51.64 | 1.56 | 0.032 / 0.023 | 0.36 | 0.01 | 0.001 / -0.008 |
| [44.21, 59.07] | [-0.18, 21.30] | [0.25, 0.48] | [-0.16, 0.17] | |||
| Collect data until significance | 33.66 | 0.30 | 0.001 / -0.009 | 0.33 | 0.02 | 0.001 / -0.007 |
| [26.33, 44.99] | [-1.45, 11.05] | [0.22, 0.45] | [-0.14, 0.19] | |||
| Optional stopping | 32.98 | -5.15 | 0.011 / 0.003 | 0.48 | 0.05 | 0.003 / -0.005 |
| [26.94, 39.03] | [-14.06, 3.75] | [0.36, 0.61] | [-0.12, 0.23] | |||
| Selective reporting studies | 54.30 | 1.41 | 0.001 / -0.008 | 0.24 | 0.04 | 0.003 / -0.005 |
| [47.36, 61.23] | [-8.71, 11.52] | [0.14, 0.34] | [-0.19, 0.10] | |||
| P-rounding | 38.28 | -2.45 | 0.002 / -0.007 | 0.12 | 0.02 | 0.001 / -0.007 |
| [3.87, 45.69] | [-13.26, 8.37] | [0.04, 0.20] | [-0.10, 0.13] | |||
| Selective reporting | 51.65 | 5.70 | 0.011 / 0.003 | 0.06 | 0.01 | 0.001 / -0.008 |
| [44.86, 58.43] | [-4.20, 15.60] | [0.01, 0.12] | [-0.08, 0.08] | |||
| Claiming effects hold in other conditions when unsure | 36.59 | 4.44 | 0.007 / -0.002 | 0.18 | 0.06 | 0.006 / -0.002 |
| [29.51, 43.68] | [-5.85, 14.74] | [0.08, 0.28] | [-0.08, 0.21] | |||
| 51.74 | 4.90 | 0.008 / -0.001 | 0.15 | -0.01 | 0.001 / -0.007 | |
| [44.57, 58.91] | [-5.51, 15.31] | [0.07, 0.24] | [-0.14, 0.11] | |||
| 59.81 | 1.68 | 0.001 / -0.008 | 0.20 | 0.08 | 0.009 / 0.001 | |
| [52.60 – 67.01] | [-8.78 – 12.14] | [0.12, 0.30] | [-0.07, 0.23] | |||
Involved = Researchers involved in COVID-19 research: CI = Confidence interval.Novel potential problematic behaviors are presented in italics.
Fig. 2Average score (plus 95% confidence intervals) for the attitudes towards academic status measure by type of involvement in COVID-19 research
Regression projects comparing researchers participating and not participating in COVID-19 research on attitudes towards research
| Intercept | Involved | R2 / R2 adjusted | |
|---|---|---|---|
| My research area is needed in crisis time | 3.63 | 0.077 / 0.069 | |
| [3.36, 3.90] | |||
| My research area results are untrustworthy | 2.74 | -0.05 | 0.001 / -0.007 |
| [2.48, 2.99] | [-0.41, 0.31] | ||
| There is a presence of inadequate incentives | 4.54 | -0.01 | 0.000 / -0.008 |
| [4.33, 4.75] | [-0.30, 0.29] | ||
| There exist fundamental issues in my research area | 4.18 | -0.20 | 0.010 / 0.002 |
| [3.93, 4.44] | [-0.56, 0.16] | ||
| Research quality should be valued more | 4.55 | 0.07 | 0.002 / -0.006 |
| [4.35, 4.76] | [-0.22, 0.36] | ||
| There exists an excess reward for publication volume | 4.49 | -0.10 | 0.003 / -0.005 |
| [4.26, 4.73] | [-0.44, 0.23] |
Involved = Researchers involved in COVID-19 research.: CI = Confidence interval. Significant differences at 0.05 level are presented bolded and in light grey.